InNexus Biotechnology Valuation
| IXSBFDelisted Stock | USD 0.0001 0.00 0.00% |
InNexus Biotechnology seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of InNexus Biotechnology from evaluating the firm fundamentals such as return on asset of -0.31, and Current Valuation of 6.69 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that InNexus Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of InNexus Biotechnology is based on 3 months time horizon. Increasing InNexus Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the InNexus stock is determined by what a typical buyer is willing to pay for full or partial control of InNexus Biotechnology. Since InNexus Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InNexus Stock. However, InNexus Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.5E-5 | Hype 1.0E-4 |
The real value of InNexus Stock, also known as its intrinsic value, is the underlying worth of InNexus Biotechnology Company, which is reflected in its stock price. It is based on InNexus Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of InNexus Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of InNexus Biotechnology helps investors to forecast how InNexus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InNexus Biotechnology more accurately as focusing exclusively on InNexus Biotechnology's fundamentals will not take into account other important factors: About InNexus Biotechnology Valuation
The delisted stock valuation mechanism determines InNexus Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of InNexus Biotechnology. We calculate exposure to InNexus Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InNexus Biotechnology's related companies.InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking technology. InNexus Biotechnology, Inc. is headquartered in Vancouver, Canada. Innexus Biotechnology is traded on OTC Exchange in the United States.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in InNexus Stock
If you are still planning to invest in InNexus Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InNexus Biotechnology's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |